Sucro Announces Guyana Sugar Refinery Joint Venture, Sale of Hamilton Refinery Assets to the JV, and Launch of Sucro Engineering Services

Stock Information for Emerald Health Therapeutics Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Emerald Health Therapeutics Inc.

Sucro Announces Third Quarter 2025 Results
Sucro to Host Third Quarter 2025 Conference Call
Sucro Completes Acquisition of Remaining 49% Ownership of Sweet Life Services Subsidiary
Canadian Investment Regulatory Organization Trade Resumption - SUGR
Sucro and Santander Sugar Group form Joint Venture for Caribbean Sugar Refinery (CSR) to Boost Regional Cane Sugar production
Canadian Investment Regulatory Organization Trading Halt - SUGR
Sucro Announces Second Quarter 2025 Results
Sucro to Host Second Quarter 2025 Conference Call

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.